NCT06182917View on ClinicalTrials.gov

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

RecruitingOBSERVATIONAL

Enrollment

35

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

June 30, 2026

Conditions

Ovarian Cancer

Trial Locations (1)

610016

RECRUITING

west china second University， SICHUAN University, China, Chengdu

All Listed Sponsors

lead

West China Second University Hospital

OTHER